These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 28366453)

  • 1. Genetic Correction of SOD1 Mutant iPSCs Reveals ERK and JNK Activated AP1 as a Driver of Neurodegeneration in Amyotrophic Lateral Sclerosis.
    Bhinge A; Namboori SC; Zhang X; VanDongen AMJ; Stanton LW
    Stem Cell Reports; 2017 Apr; 8(4):856-869. PubMed ID: 28366453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coactivation of GSK3β and IGF-1 Attenuates Amyotrophic Lateral Sclerosis Nerve Fiber Cytopathies in SOD1 Mutant Patient-Derived Motor Neurons.
    Ting HC; Yang HI; Harn HJ; Chiu IM; Su HL; Li X; Chen MF; Ho TJ; Liu CA; Tsai YJ; Chiou TW; Lin SZ; Chang CY
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs.
    Wang L; Yi F; Fu L; Yang J; Wang S; Wang Z; Suzuki K; Sun L; Xu X; Yu Y; Qiao J; Belmonte JCI; Yang Z; Yuan Y; Qu J; Liu GH
    Protein Cell; 2017 May; 8(5):365-378. PubMed ID: 28401346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced pluripotent stem cell-derived motor neurons from amyotrophic lateral sclerosis (ALS) patients carrying different superoxide dismutase 1 mutations recapitulate pathological features of ALS.
    Liu WC; Liu N; Wang Y; Huang C; Li YF; Wang H; Li XG; Deng M
    Chin Med J (Engl); 2021 Oct; 134(20):2457-2464. PubMed ID: 34669638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons.
    Chen H; Qian K; Du Z; Cao J; Petersen A; Liu H; Blackbourn LW; Huang CL; Errigo A; Yin Y; Lu J; Ayala M; Zhang SC
    Cell Stem Cell; 2014 Jun; 14(6):796-809. PubMed ID: 24704493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAP4K4 Activation Mediates Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis.
    Wu C; Watts ME; Rubin LL
    Cell Rep; 2019 Jan; 26(5):1143-1156.e5. PubMed ID: 30699345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered calcium dynamics and glutamate receptor properties in iPSC-derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations.
    Bursch F; Kalmbach N; Naujock M; Staege S; Eggenschwiler R; Abo-Rady M; Japtok J; Guo W; Hensel N; Reinhardt P; Boeckers TM; Cantz T; Sterneckert J; Van Den Bosch L; Hermann A; Petri S; Wegner F
    Hum Mol Genet; 2019 Sep; 28(17):2835-2850. PubMed ID: 31108504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-cell transcriptomics identifies master regulators of neurodegeneration in SOD1 ALS iPSC-derived motor neurons.
    Namboori SC; Thomas P; Ames R; Hawkins S; Garrett LO; Willis CRG; Rosa A; Stanton LW; Bhinge A
    Stem Cell Reports; 2021 Dec; 16(12):3020-3035. PubMed ID: 34767750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downstream Effects of Mutations in
    Dash BP; Freischmidt A; Weishaupt JH; Hermann A
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.
    Coatti GC; Frangini M; Valadares MC; Gomes JP; Lima NO; Cavaçana N; Assoni AF; Pelatti MV; Birbrair A; de Lima ACP; Singer JM; Rocha FMM; Da Silva GL; Mantovani MS; Macedo-Souza LI; Ferrari MFR; Zatz M
    Stem Cell Rev Rep; 2017 Oct; 13(5):686-698. PubMed ID: 28710685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Aminopyridine Induced Activity Rescues Hypoexcitable Motor Neurons from Amyotrophic Lateral Sclerosis Patient-Derived Induced Pluripotent Stem Cells.
    Naujock M; Stanslowsky N; Bufler S; Naumann M; Reinhardt P; Sterneckert J; Kefalakes E; Kassebaum C; Bursch F; Lojewski X; Storch A; Frickenhaus M; Boeckers TM; Putz S; Demestre M; Liebau S; Klingenstein M; Ludolph AC; Dengler R; Kim KS; Hermann A; Wegner F; Petri S
    Stem Cells; 2016 Jun; 34(6):1563-75. PubMed ID: 26946488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrative miRNA-mRNA expression analysis identifies miRNA signatures associated with SOD1 and TARDBP patient-derived motor neurons.
    Dash BP; Freischmidt A; Weishaupt JH; Hermann A
    Hum Mol Genet; 2024 Jul; 33(15):1300-1314. PubMed ID: 38676626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting low levels of MIF expression as a potential therapeutic strategy for ALS.
    Alfahel L; Gschwendtberger T; Kozareva V; Dumas L; Gibbs R; Kertser A; Baruch K; Zaccai S; Kahn J; Thau-Habermann N; Eggenschwiler R; Sterneckert J; Hermann A; Sundararaman N; Vaibhav V; Van Eyk JE; Rafuse VF; Fraenkel E; Cantz T; Petri S; Israelson A
    Cell Rep Med; 2024 May; 5(5):101546. PubMed ID: 38703766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic Insights of Astrocyte-Mediated Hyperactive Autophagy and Loss of Motor Neuron Function in SOD1
    Rajpurohit CS; Kumar V; Cheffer A; Oliveira D; Ulrich H; Okamoto OK; Zatz M; Ansari UA; Khanna VK; Pant AB
    Mol Neurobiol; 2020 Oct; 57(10):4117-4133. PubMed ID: 32676988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
    Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
    Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALS.
    Luisier R; Tyzack GE; Hall CE; Mitchell JS; Devine H; Taha DM; Malik B; Meyer I; Greensmith L; Newcombe J; Ule J; Luscombe NM; Patani R
    Nat Commun; 2018 May; 9(1):2010. PubMed ID: 29789581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant axon branching via Fos-B dysregulation in FUS-ALS motor neurons.
    Akiyama T; Suzuki N; Ishikawa M; Fujimori K; Sone T; Kawada J; Funayama R; Fujishima F; Mitsuzawa S; Ikeda K; Ono H; Shijo T; Osana S; Shirota M; Nakagawa T; Kitajima Y; Nishiyama A; Izumi R; Morimoto S; Okada Y; Kamei T; Nishida M; Nogami M; Kaneda S; Ikeuchi Y; Mitsuhashi H; Nakayama K; Fujii T; Warita H; Okano H; Aoki M
    EBioMedicine; 2019 Jul; 45():362-378. PubMed ID: 31262712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of proteome-wide degradation dynamics in ALS SOD1 iPSC-derived patient neurons reveals disrupted VCP homeostasis.
    Tsioras K; Smith KC; Edassery SL; Garjani M; Li Y; Williams C; McKenna ED; Guo W; Wilen AP; Hark TJ; Marklund SL; Ostrow LW; Gilthorpe JD; Ichida JK; Kalb RG; Savas JN; Kiskinis E
    Cell Rep; 2023 Oct; 42(10):113160. PubMed ID: 37776851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissues.
    Bayer H; Lang K; Buck E; Higelin J; Barteczko L; Pasquarelli N; Sprissler J; Lucas T; Holzmann K; Demestre M; Lindenberg KS; Danzer KM; Boeckers T; Ludolph AC; Dupuis L; Weydt P; Witting A
    Neurobiol Dis; 2017 Jan; 97(Pt A):36-45. PubMed ID: 27818323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyotrophic lateral sclerosis models derived from human embryonic stem cells with different superoxide dismutase 1 mutations exhibit differential drug responses.
    Isobe T; Tooi N; Nakatsuji N; Aiba K
    Stem Cell Res; 2015 Nov; 15(3):459-468. PubMed ID: 26413785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.